505 related articles for article (PubMed ID: 28552793)
21. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
22. Paeoniflorin in experimental BALB/c mansoniasis: A novel anti-angiogenic therapy.
Abd El-Aal NF; Abdelbary EH
Exp Parasitol; 2019 Feb; 197():85-92. PubMed ID: 30414842
[TBL] [Abstract][Full Text] [Related]
23. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
24. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
[TBL] [Abstract][Full Text] [Related]
25. Schistosomicidal and hepatoprotective activity of gamma-aminobutyric acid (GABA) alone or combined with praziquantel against Schistosoma mansoni infection in murine model.
Fahmy AM; William S; Hegab A; Tm D
Exp Parasitol; 2022 Jul; 238():108260. PubMed ID: 35447136
[TBL] [Abstract][Full Text] [Related]
26. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
Botros SS; Hammam O; Mahmoud M; Bergquist R
APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the antiparasitic and antifibrotic effects of gallic acid on experimental hepatic schistosomiasis
Sharaf-El-Deen S; Soliman S; Brakat R
J Helminthol; 2024 Jan; 98():e3. PubMed ID: 38167243
[TBL] [Abstract][Full Text] [Related]
28. Parasitological and histopathological studies to the effect of aqueous extract of Moringa oleifera Lam. leaves combined with praziquantel therapy in modulating the liver and spleen damage induced by Schistosoma mansoni to male mice.
Saad El-Din MI; Gad El-Hak HN; Ghobashy MA; Elrayess RA
Environ Sci Pollut Res Int; 2023 Feb; 30(6):15548-15560. PubMed ID: 36169837
[TBL] [Abstract][Full Text] [Related]
29. Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate.
Hanallah S; El-Lakkany N; Mahmoud S; Mousa M; Botros S
APMIS; 2003 Dec; 111(12):1125-32. PubMed ID: 14678022
[TBL] [Abstract][Full Text] [Related]
30. A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice.
Liu M; Wu Q; Chen P; Büchele B; Bian M; Dong S; Huang D; Ren C; Zhang Y; Hou X; Simmet T; Shen J
PLoS One; 2014; 9(6):e100129. PubMed ID: 24941000
[TBL] [Abstract][Full Text] [Related]
31. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
Sabra AA; Salem MB; William S; Hammam OA; El-Lakkany NM
Exp Parasitol; 2022 Aug; 239():108293. PubMed ID: 35667394
[TBL] [Abstract][Full Text] [Related]
32. Ginger (Zingiber Officinale)-derived nanoparticles in Schistosoma mansoni infected mice: Hepatoprotective and enhancer of etiological treatment.
Abd El Wahab WM; El-Badry AA; Mahmoud SS; El-Badry YA; El-Badry MA; Hamdy DA
PLoS Negl Trop Dis; 2021 May; 15(5):e0009423. PubMed ID: 34014936
[TBL] [Abstract][Full Text] [Related]
33. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effect of the alkaloidic extract of Solanum lycocarpum fruits in mice infected with Schistosoma mansoni.
Miranda MA; Kuehn CC; Cardoso JF; Oliveira LG; Magalhães LG; Tiossi RF; Rodrigues V; Zucolloto S; Prado JC; McChesney JD; Bastos JK
Exp Parasitol; 2013 Apr; 133(4):396-402. PubMed ID: 23298540
[TBL] [Abstract][Full Text] [Related]
36. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
[TBL] [Abstract][Full Text] [Related]
37. Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
Helmy MM; Mahmoud SS; Fahmy ZH
Exp Parasitol; 2009 Aug; 122(4):310-7. PubMed ID: 19389399
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the schistosomicidal, antioxidant and anti-inflammatory activities of the ethyl acetate fraction from Ozoroa pulcherrima Schweinf. Roots on Schistosoma mansoni-induced liver pathology in mice and its phytochemical characterization.
Jatsa HB; Feussom NG; Femoe UM; Kenfack MC; Nkondo ET; Kadji Fassi JB; Simo ND; Moaboulou C; Dongmo CN; Tsague CD; Dongo E; Kamtchouing P; Tchuem Tchuente LA
J Ethnopharmacol; 2019 Jun; 238():111883. PubMed ID: 30999012
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
[TBL] [Abstract][Full Text] [Related]
40. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
Khayeka-Wandabwa C; Zhou G; Magak NG; Choge JK; Kemei WK; Makwali JA; Karani LW; Kisavi MP; Ndulu JV; Anjili CO
Exp Parasitol; 2019 Sep; 204():107728. PubMed ID: 31348915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
